$DLB

Florida Atlantic University said Dolby Laboratories acquired a video-compression patent portfolio developed via a partnership with OP Solutions. The assets relate to Versatile Video Coding (VVC, H.266), finalized in 2020, which can cut video data needs about 50% versus HEVC at similar quality. The portfolio includes 683 IP assets and 16 U.S. patents declared essential to VVC, licensed via the Access Advance pool.

Dolby Laboratories and Hisense announced a rollout of Dolby Vision 2, starting with select Hisense TV models. The format will reach North America, Europe, and APAC via firmware updates, supporting existing Dolby Vision content and new titles across film, TV, games, and live sports. Streaming platforms including CANAL+, iQIYI, and Peacock plan to use it. Initial support covers Hisense UX, UR9, UR8, and U7 series.

Dolby Laboratories (DLB) and Hisense launched Dolby Vision 2 on select TVs, with CANAL+, iQIYI and Peacock committing to use the feature, according to the article. DLB shares closed at $61.77, up 24.04% over 30 days but down 13% over 1 year. Simply Wall St estimates fair value at $78.33 and cites risks from royalty-free codecs and weaker TV/set-top demand.

Dolby Laboratories and Hisense said Dolby Vision 2 will roll out via a free over-the-air firmware update to select 2026 Hisense TVs in North America, Europe, and APAC over coming weeks. Supported models include Hisense UX (flagship series) and UR9, UR8, and U7 (Google TV or VIDAA OS). Dolby Vision 2 adds new tone-mapping controls and splits into Dolby Vision 2 and Dolby Vision 2 Max.

Dolby Laboratories and Hisense said Dolby Vision 2 is rolling out on select Hisense smart TVs via firmware. The initial models include Hisense 2026 UX, UR9, UR8 and U7 series (U7 Pro in some regions) in North America, Europe and Asia-Pacific, with more updates planned. Dolby Vision 2 adds a new image engine, Content Intelligence, and an intensity slider, with Dolby Vision 2 Max adding features like Authentic Motion and Light Sense 2.

Dolby Laboratories (NYSE: DLB) shares rose about 12.6% in late July as investors reacted to results and raised guidance. The company reported Q3 adjusted EPS of $0.69 vs $0.67 consensus, revenue of $305M vs about $312M expected, and increased its buyback authorization by $350M. Free cash flow was about $152M, supporting dividends and repurchases.

Dolby Laboratories’ Q3 2026 earnings call said it is shifting toward content platforms and usage-based revenue, targeting 10% of total revenue from partners by FY2028. Management cited traction for its Video Distribution Program, including Meta and Alibaba deals, and a China-first automotive strategy. Q4 guidance calls for 23% YoY revenue growth, with a $4M restructuring charge and a $350M share repurchase authorization increase.

Dolby Laboratories (NYSE: DLB) shares rose 11.7% by 10:45 a.m. ET after its fiscal Q3 2026 results. The company reported revenue of $305 million versus an estimated $312 million, and EPS of $0.69 versus $0.67 expected. GAAP EPS was $0.30. Dolby guided Q4 sales to $362 million-$392 million and full-year revenue to at least $1.4 billion.

Thursday, July 30, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Peter L. Goldmacher Chief Executive Officer - Kevin J. Yeaman Chief Financial Officer - Robert J. Park TAKEAWAYS Revenue -- $305 million, falling within management guidance ranges despite timing-related impacts in foundational audio. Non-GAAP EPS -- $0.69, exceeding the midpoint of guidance as lower operating expenses helped offset revenue shifts.

Audio and video technology company Dolby Laboratories (NYSE: DLB) missed Wall Street’s revenue expectations in Q2 CY2026, with sales falling 3.3% year on year to $305 million. On the other hand, next quarter’s outlook exceeded expectations with revenue guided to $377 million at the midpoint, or 7.4% above analysts’ estimates. Its non-GAAP profit of $0.69 per share was 3% above analysts’ consensus estimates. Is now the time to buy Dolby Laboratories?